These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


811 related items for PubMed ID: 10769714

  • 21. Prognostic significance of allelic imbalances on chromosome 9p in stage I non-small cell lung carcinoma.
    Tomizawa Y, Adachi J, Kohno T, Hamada K, Saito R, Noguchi M, Matsuno Y, Hirohashi S, Yamaguchi N, Yokota J.
    Clin Cancer Res; 1999 May; 5(5):1139-46. PubMed ID: 10353749
    [Abstract] [Full Text] [Related]

  • 22. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
    Kale A, Söylemez F, Ensari A.
    Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
    [Abstract] [Full Text] [Related]

  • 23. Basaloid squamous carcinoma of the oral cavity: report of 2 cases and study of AgNOR, PCNA, p53, and MMP expression.
    Coletta RD, Cotrim P, Vargas PA, Villalba H, Pires FR, de Moraes M, de Almeida OP.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):563-9. PubMed ID: 11346736
    [Abstract] [Full Text] [Related]

  • 24. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.
    Kawasaki M, Nakanishi Y, Kuwano K, Yatsunami J, Takayama K, Hara N.
    Clin Cancer Res; 1997 Jul; 3(7):1195-200. PubMed ID: 9815799
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A prognostic model of survival in surgically resected squamous cell carcinoma of the lung using clinical, pathologic, and biologic markers.
    Bernardi FD, Antonângelo L, Beyruti R, Takagaki T, Saldiva PH, Capelozzi VL.
    Mod Pathol; 1997 Oct; 10(10):992-1000. PubMed ID: 9346178
    [Abstract] [Full Text] [Related]

  • 27. Absence of prognostic significance of p21(WAF1/CIP1) protein expression in non-small cell lung cancer.
    Dworakowska D, Jassem E, Jassem J, Boltze C, Wiedorn KH, Dworakowski R, Skokowski J, Jaśkiewicz K, Czestochowska E.
    Acta Oncol; 2005 Oct; 44(1):75-9. PubMed ID: 15848909
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Artificial neural networks and logistic regression as tools for prediction of survival in patients with Stages I and II non-small cell lung cancer.
    Marchevsky AM, Patel S, Wiley KJ, Stephenson MA, Gondo M, Brown RW, Yi ES, Benedict WF, Anton RC, Cagle PT.
    Mod Pathol; 1998 Jul; 11(7):618-25. PubMed ID: 9688182
    [Abstract] [Full Text] [Related]

  • 30. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
    Kao JT, Chuah SK, Huang CC, Chen CL, Wang CC, Hung CH, Chen CH, Wang JH, Lu SN, Lee CM, Changchien CS, Hu TH.
    Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. p53 protein in non-small cell lung cancer as quantitated by enzyme-linked immunosorbent assay: relation to prognosis.
    Pappot H, Francis D, Brünner N, Grondahl-Hansen J, Osterlind K.
    Clin Cancer Res; 1996 Jan; 2(1):155-60. PubMed ID: 9816102
    [Abstract] [Full Text] [Related]

  • 33. Proliferating cell nuclear antigen may be superior to argyrophilic nucleolar organizer regions in predicting shortened survival of patients with non-small cell lung cancer.
    Oyama T, Mitsudomi T, Mizoue T, Ohgami A, Osaki T, Nakanishi R, Yasumoto K.
    Surg Oncol; 1995 Jan; 4(2):83-9. PubMed ID: 7551263
    [Abstract] [Full Text] [Related]

  • 34. Human non-small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression.
    Fontanini G, Vignati S, Bigini D, Merlo GR, Ribecchini A, Angeletti CA, Basolo F, Pingitore R, Bevilacqua G.
    J Pathol; 1994 Sep; 174(1):23-31. PubMed ID: 7965400
    [Abstract] [Full Text] [Related]

  • 35. [A comparison of proliferating cell nuclear antigen immunostaining, nucleolar organizer region staining in lung cancer].
    Zhao T, Zhang YL, Li CD.
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Dec; 16(6):342-4, 374. PubMed ID: 7913415
    [Abstract] [Full Text] [Related]

  • 36. Correlation between survivin expression and prognosis in non-small cell lung cancer.
    Atikcan S, Unsal E, Demirag F, Köksal D, Yilmaz A.
    Respir Med; 2006 Dec; 100(12):2220-6. PubMed ID: 16650973
    [Abstract] [Full Text] [Related]

  • 37. The prognostic value of proliferating cell nuclear antigen (PCNA) and p53 protein expression in patients with advanced nasopharyngeal carcinoma.
    Wang LF, Chai CY, Kuo WR, Tai CF, Lee KW, Ho KY.
    Acta Otolaryngol; 2006 Jul; 126(7):769-74. PubMed ID: 16803719
    [Abstract] [Full Text] [Related]

  • 38. [Relationship between expressions of p53, c-erbB2 genes, proliferating cell nuclear antigen and prognosis of patients with ovarian epithelial carcinoma].
    Li JD, Li MD, Li YF, Huang X, Liu JH, Liu FY, Zhang CQ.
    Ai Zheng; 2002 Mar; 21(3):292-6. PubMed ID: 12451998
    [Abstract] [Full Text] [Related]

  • 39. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S, Kwok Y, Krasna M, Bangalore M, Suntharalingam M.
    Int J Radiat Oncol Biol Phys; 2005 Aug 01; 62(5):1438-43. PubMed ID: 16029805
    [Abstract] [Full Text] [Related]

  • 40. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer.
    Graziano SL, Tatum AH, Newman NB, Oler A, Kohman LJ, Veit LJ, Gamble GP, Coleman MJ, Barmada S, O'Lear S.
    Cancer Res; 1994 Jun 01; 54(11):2908-13. PubMed ID: 8187076
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 41.